Matches in SemOpenAlex for { <https://semopenalex.org/work/W169172330> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W169172330 abstract "Background: Levosimendan, a novel inodilator, has been shown to improve hemodynamic function in acute heart failure and cardiogenic shock following acute myocardial infarction. Limited data are available on its use in patients with impaired right ventricular function. We hypothesised that levosimendan, due to its vasodilating and positiv inotropic profile, could ameliorate right ventricular hemodynamic function in critically ill patients with cardiogenic shock following myocardial infarction. Methods: Patients (n=25) with cardiogenic shock received initial conventional inotropic therapy after reperfusion of infarct related artery. After insufficient hemodynamic improvement patients received levosimendan (2μg/kgbw/h) over 24 hours. Hemodynamic measurements were routinely performed initially i.e., − 24 hours, at baseline (prior to levosimendan infusion) at 3 hours, 24 and 48 hours after start of levosimendan infusion using a Swan-Ganz thermodilution catheter. Results: With conventional catecholamine therapy (i.e., norepinephrine and/or dobutamine) we observed only marginal change of right ventricular perfomance parameters. In contrast, upon levosimendan infusion there was a significant decrease in pulmonary vascular resistance, while right ventricular Cardiac Power Index, a new measure of right ventricular performance similar to left ventricular CPI, significantly increased. Central venous pressure did not change which makes a significant dependency on preload unlikely. Conclusion: Levosimendan infusion in patients with cardiogenic shock following acute MI and PCI seems to improves substantially and persistently right ventricular hemodynamic parameters, superior to conventional catecholamine therapy. Further studies addressing the benefit of levosimendan in right ventricular failure like in cardiogenic shock due to right myocardial infarction or acute pulmonary embolism are warranted. Hemodynamic Parameters With Catecholamine Teatment and Additional Levosimendan" @default.
- W169172330 created "2016-06-24" @default.
- W169172330 creator A5013590347 @default.
- W169172330 creator A5016532986 @default.
- W169172330 creator A5034332284 @default.
- W169172330 creator A5038971858 @default.
- W169172330 creator A5063260594 @default.
- W169172330 creator A5068544067 @default.
- W169172330 creator A5070006952 @default.
- W169172330 creator A5077493059 @default.
- W169172330 date "2007-10-16" @default.
- W169172330 modified "2023-10-06" @default.
- W169172330 title "Abstract 3380: Levosimendan Improves Right Ventricular Function In Cardiogenic Shock Following Myocardial Infarction" @default.
- W169172330 doi "https://doi.org/10.1161/circ.116.suppl_16.ii_762-c" @default.
- W169172330 hasPublicationYear "2007" @default.
- W169172330 type Work @default.
- W169172330 sameAs 169172330 @default.
- W169172330 citedByCount "0" @default.
- W169172330 crossrefType "journal-article" @default.
- W169172330 hasAuthorship W169172330A5013590347 @default.
- W169172330 hasAuthorship W169172330A5016532986 @default.
- W169172330 hasAuthorship W169172330A5034332284 @default.
- W169172330 hasAuthorship W169172330A5038971858 @default.
- W169172330 hasAuthorship W169172330A5063260594 @default.
- W169172330 hasAuthorship W169172330A5068544067 @default.
- W169172330 hasAuthorship W169172330A5070006952 @default.
- W169172330 hasAuthorship W169172330A5077493059 @default.
- W169172330 hasConcept C126322002 @default.
- W169172330 hasConcept C139940330 @default.
- W169172330 hasConcept C146556889 @default.
- W169172330 hasConcept C155710745 @default.
- W169172330 hasConcept C164705383 @default.
- W169172330 hasConcept C178853913 @default.
- W169172330 hasConcept C2776645727 @default.
- W169172330 hasConcept C2776850375 @default.
- W169172330 hasConcept C2777335384 @default.
- W169172330 hasConcept C2781185063 @default.
- W169172330 hasConcept C2781300812 @default.
- W169172330 hasConcept C31861589 @default.
- W169172330 hasConcept C42219234 @default.
- W169172330 hasConcept C48277249 @default.
- W169172330 hasConcept C500558357 @default.
- W169172330 hasConcept C71924100 @default.
- W169172330 hasConceptScore W169172330C126322002 @default.
- W169172330 hasConceptScore W169172330C139940330 @default.
- W169172330 hasConceptScore W169172330C146556889 @default.
- W169172330 hasConceptScore W169172330C155710745 @default.
- W169172330 hasConceptScore W169172330C164705383 @default.
- W169172330 hasConceptScore W169172330C178853913 @default.
- W169172330 hasConceptScore W169172330C2776645727 @default.
- W169172330 hasConceptScore W169172330C2776850375 @default.
- W169172330 hasConceptScore W169172330C2777335384 @default.
- W169172330 hasConceptScore W169172330C2781185063 @default.
- W169172330 hasConceptScore W169172330C2781300812 @default.
- W169172330 hasConceptScore W169172330C31861589 @default.
- W169172330 hasConceptScore W169172330C42219234 @default.
- W169172330 hasConceptScore W169172330C48277249 @default.
- W169172330 hasConceptScore W169172330C500558357 @default.
- W169172330 hasConceptScore W169172330C71924100 @default.
- W169172330 hasIssue "suppl_16" @default.
- W169172330 hasLocation W1691723301 @default.
- W169172330 hasOpenAccess W169172330 @default.
- W169172330 hasPrimaryLocation W1691723301 @default.
- W169172330 hasRelatedWork W169172330 @default.
- W169172330 hasRelatedWork W2063412307 @default.
- W169172330 hasRelatedWork W2067361909 @default.
- W169172330 hasRelatedWork W2151693723 @default.
- W169172330 hasRelatedWork W2789560201 @default.
- W169172330 hasRelatedWork W2888966315 @default.
- W169172330 hasRelatedWork W3037295193 @default.
- W169172330 hasRelatedWork W3166211984 @default.
- W169172330 hasRelatedWork W3192489984 @default.
- W169172330 hasRelatedWork W586430160 @default.
- W169172330 hasVolume "116" @default.
- W169172330 isParatext "false" @default.
- W169172330 isRetracted "false" @default.
- W169172330 magId "169172330" @default.
- W169172330 workType "article" @default.